ENCELTO™ (revakinagene taroretcel-lwey)
| Full Name | ENCELTO™ (revakinagene taroretcel-lwey) |
| Drug | Encelto |
| Manufacturer | Neurotech Pharmaceuticals, Inc. |
| Route of Administration | Intravitreal |
| Site of Care | Healthcare facility |
| Approved Indication | Indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel) |
| Disease | Idiopathic macular telangiectasia type 2 (MacTel) |
| Therapeutic Area | Ophthalmology; Cell & Gene Therapy |
| Enrollment Form Link | Start Form |
| Phone Number | 888-477-1165 |
| Product Website | ENCELTO.com/ecp |